Phase II Study of Grass Pollen Allergy Vaccine BM32

Clinical trial NCT01538979 · COMPLETED

Trial details

NCT number: NCT01538979
Sponsor: Biomay AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Grass Pollen Allergy

Start date: 2012-03-01
Primary completion: 2014-12-01
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.